In silico structure-function analysis of pathological variation in the HSD11B2 gene sequence

Area of Science:

• Biochemistry
• Genetics
• Cardiovascular Physiology

Background:

• 11beta-hydroxysteroid dehydrogenase type 2 (11betaHSD2) inactivates cortisol, preventing mineralocorticoid receptor (MR) overactivation and hypertension.
• Defects in HSD11B2 cause apparent mineralocorticoid excess (AME), a rare Mendelian hypertensive disorder.
• HSD11B2 gene variations are linked to salt sensitivity and cardiovascular risk in the general population.

Purpose of the Study:

• To investigate the structural and functional consequences of HSD11B2 mutations using a 3D homology model.
• To correlate specific HSD11B2 mutations with the severity of apparent mineralocorticoid excess (AME).
• To elucidate potential molecular mechanisms underlying AME pathogenesis.

Main Methods:

• Construction of a three-dimensional homology model for 11betaHSD2.
• Analysis of published HSD11B2 mutations within the structural model.
• Prediction of mutation impact on protein structure, stability, and dimerization.

Main Results:

• A strong genotype-phenotype correlation was observed for AME, with severe mutations impacting conserved protein regions.
• Mutations in less conserved regions predicted milder phenotypes, suggesting greater tolerance to substitution.
• Pathogenic mutations were identified in regions potentially involved in protein dimerization and stabilization.

Conclusions:

• The 3D model effectively predicts the functional impact of HSD11B2 mutations on 11betaHSD2 activity and AME severity.
• Mutation location within conserved or less conserved regions correlates with disease phenotype.
• Structural insights suggest that disruption of protein stabilization or dimerization contributes to AME pathogenesis.